Pharma Marketing Network
APRIL 27, 2025
Regulatory Constraints HIPAA, GDPR, and FDA guidelines shape how leads are collected, stored, and contacted. Webinars, white papers, and CME resources are particularly effective. Use clear opt-ins, partner with HIPAA-compliant vendors, and consult regulatory affairs to ensure all outreach meets FDA and GDPR standards.
Pharma Marketing Network
MAY 21, 2025
Educational Content That Builds Trust White papers, webinars, CME-accredited courses, and disease-state guides work exceptionally well when the goal is to offer value in exchange for contact information. Use opt-in consent language that aligns with GDPR and HIPAA. However, this content must go beyond surface-level education.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
FEBRUARY 5, 2025
Engage in scientific dialogues by sharing white papers and expert opinions. HIPAA and GDPR laws protecting patient privacy. The biggest risks involve misleading claims, unapproved user comments, and privacy violations (HIPAA/GDPR compliance issues). Pharma brands can: Join relevant hashtags (e.g.,
Pharma Marketing Network
DECEMBER 19, 2024
Education and Training: Provide resources like webinars or white papers to engage HCPs effectively. Solution: Partner with legal and compliance teams to ensure all campaigns adhere to FDA and HIPAA guidelines. By defining these audiences clearly, pharma brands can create messages that resonate and build trust.
Pharma Marketing Network
DECEMBER 31, 2024
High-quality blog posts, white papers, and case studies can boost your visibility. Ensure your campaigns comply with regulations like HIPAA and communicate your commitment to safeguarding patient data. Chatbots, for instance, are becoming invaluable for answering patient queries or booking appointments.
Expert insights. Personalized for you.
52 
Let's personalize your content